Walnut Creek, California
CNS medication trials in Walnut Creek, CA
24 CNS medication studies are recruiting participants at sites in Walnut Creek as of November 17, 2026, according to ClinicalTrials.gov. CNS Medication Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Walnut Creek at a glance
- 24 studies are recruiting at a site in Walnut Creek.
- By phase: Phase 2 (8), Phase 3 (16).
- By sponsor: industry (24).
- By research area: Migraine (9), Depression (8), Schizophrenia (4), ADHD (2), Parkinson's Disease (1).
- Most recent update to one of these records: November 17, 2026.
Depression studies recruiting in Walnut Creek
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Sunwise Clinical Research
- Registry record
- NCT07573176 · updated
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Registry record
- NCT07621237 · updated
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07484217 · updated
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Study site
- Vanda Investigational Site
- Registry record
- NCT06830044 · updated
Brexanolone Lifting Outcomes Of Moms
- Phase 3
- Ages 15 to 45
- Female participants
- Sponsor
- Lipocine Inc.
- Study site
- Lipocine Investigational Site
- Registry record
- NCT07822321 · updated
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Syndeio Biosciences, Inc
- Study site
- Sunwise Clinical Research LLC
- Registry record
- NCT06547489 · updated
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- AbbVie
- Study site
- Sunwise Clinical Research /ID# 277555
- Registry record
- NCT07276997 · updated
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Autobahn Therapeutics, Inc.
- Study site
- Autobahn Site #126
- Registry record
- NCT06633016 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Walnut Creek, CA on ClinicalTrials.gov.
Schizophrenia studies recruiting in Walnut Creek
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Sunwise Clinical Research
- Registry record
- NCT06540833 · updated
A Study of Brenipatide in Adult Participants With Schizophrenia
- Phase 2
- Ages 18 to 55
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Sunwise Clinical Research
- Registry record
- NCT07410507 · updated
Randomized Withdrawal Study in Patients With Schizophrenia
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Study site
- Vanda Investigational Site
- Registry record
- NCT06961968 · updated
Study of ALTO-101 in Patients With Schizophrenia
- Phase 2
- Ages 21 to 55
- All sexes
- Sponsor
- Alto Neuroscience
- Registry record
- NCT06502964 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Walnut Creek, CA on ClinicalTrials.gov.
ADHD studies recruiting in Walnut Creek
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717892 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Walnut Creek, CA on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Walnut Creek
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- John Muir Health Cancer Center ( Site 6028)
- Registry record
- NCT06952504 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Walnut Creek, CA on ClinicalTrials.gov.
Migraine studies recruiting in Walnut Creek
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Study site
- Diablo Clinical Research dba Flourish Research
- Registry record
- NCT07616128 · updated
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study sites
- Diablo Clinical Research · Sunwise Clinical Research
- Registry record
- NCT07645924 · updated
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study sites
- Diablo Clinical Research · Sunwise Clinical Research
- Registry record
- NCT07674654 · updated
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Sunwise Clinical Research
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Sunwise Clinical Research
- Registry record
- NCT04743141 · updated
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Sunwise Clinical Research /ID# 270431
- Registry record
- NCT06810505 · updated
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Sunwise Clinical Research /ID# 248529
- Registry record
- NCT05711394 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Sunwise Clinical Research /ID# 230971
- Registry record
- NCT05125302 · updated
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- Phase 3
- Ages 18 to 45
- Female participants
- Sponsor
- Pfizer
- Study site
- Diablo Clinical Research, Inc.
- Registry record
- NCT06641466 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Walnut Creek, CA on ClinicalTrials.gov.
Ask about studies near Walnut Creek
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
168 studies recruiting across 83 cities.
Los Angeles
37 studies recruiting.
Orange
35 studies recruiting.
Anaheim
25 studies recruiting.
San Diego
25 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.
CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections